Georgia Heart Institute, Gainesville, GA 30501, USA.
Northeast Georgia Health System, Gainesville, GA 30501, USA.
Cardiol Clin. 2022 Aug;40(3):321-328. doi: 10.1016/j.ccl.2022.03.007. Epub 2022 Mar 29.
The Coronavirus disease 2019 (COVID-19) pandemic has led to a significant increase in worldwide morbidity and mortality. Patients with COVID-19 are at risk for developing a variety of cardiovascular conditions including acute coronary syndromes, stress-induced cardiomyopathy, and myocarditis. Patients with COVID-19 who develop ST-elevation myocardial infarction (STEMI) are at a higher risk of morbidity and mortality when compared with their age- and sex-matched STEMI patients without COVID-19. We review current knowledge on the pathophysiology of STEMI in patients with COVID-19, clinical presentation, outcomes, and the effect of the COVID-19 pandemic on overall STEMI care.
2019 年冠状病毒病（COVID-19）大流行导致全球发病率和死亡率显著上升。COVID-19 患者有发生多种心血管疾病的风险，包括急性冠状动脉综合征、应激性心肌病和心肌炎。与没有 COVID-19 的年龄和性别匹配的 STEMI 患者相比，发生 ST 段抬高型心肌梗死（STEMI）的 COVID-19 患者的发病率和死亡率更高。我们回顾了 COVID-19 患者 STEMI 的病理生理学、临床表现、结局以及 COVID-19 大流行对整体 STEMI 治疗的影响方面的现有知识。
